Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FADeS: Fractional Laser + Sculptra for Striae
NCT03858543Phase 1Completed
- Sponsor
- Henry Ford Health
- Start
- Jul 2019
- Primary completion
- Jan 2021
- Modality
- Polymer-based Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of poly(L-lactic acid) in striae distensae (SD) (2 arms), sponsored by Henry Ford Health. Primary endpoint: Change in Stretch Mark Size at 6 months. Started Jul 2019; status: completed.
02
Drugs
poly(L-lactic acid)
03
Conditions
striae distensae (SD)
Beyond the preview
Go deeper on NCT03858543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03858543.